Note 19 - Segment Reporting (Tables)

9 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Rx			Consumer Health			Consolidated
	(in thousands)
Three Months Ended March 31, 2024
Net revenue	$	14,025		$	3,968		$	17,993
Loss from operations	$	(1,598	)	$	(866	)	$	(2,464	)
Depreciation and amortization	$	1,449		$	385		$	1,834
Stock-based compensation expense	$	699		$	112		$	811
Three Months Ended March 31, 2023
Net revenue	$	13,805		$	8,928		$	22,733
Loss from operations	$	(7,122	)	$	(1,436	)	$	(8,558	)
Depreciation and amortization	$	1,563		$	280		$	1,843
Stock-based compensation expense	$	788		$	114		$	902

	Rx			Consumer Health			Consolidated
	(in thousands)
Nine Months Ended March 31, 2024
Net revenue	$	50,590		$	12,436		$	63,026
Income (loss) from operations	$	682		$	(2,286	)	$	(1,604	)
Depreciation and amortization	$	4,513		$	1,161		$	5,674
Stock-based compensation expense	$	2,131		$	430		$	2,561
Nine Months Ended March 31, 2023
Net revenue	$	50,486		$	26,181		$	76,667
Loss from operations	$	(13,579	)	$	(3,655	)	$	(17,234	)
Depreciation and amortization	$	4,709		$	842		$	5,551
Impairment expense	$	2,600		$	—		$	2,600
Stock-based compensation expense	$	4,937		$	209		$	5,146